Abstract
Diphenyl diselenide (PhSe)2, an organoselenium compound, has been studied as a potential pharmacological agent in different in vitro and in vivo models, mainly due to its antioxidant properties. However, there are few studies concerning the effects of (PhSe)2 on dopaminergic system. Thus, the purpose of the present study was to evaluate the effects of acute and sub-chronic treatment of (PhSe)2 on amphetamine-induced behavioral and biochemical parameters. In acute protocol, mice were pre-treated with 5 or 10 mg/kg of (PhSe)2 and 30 min after, amphetamine was administered. In sub-chronic protocol, mice were pre-treated with 5 or 10 mg/kg of (PhSe)2 during 7 days and 24 h after, amphetamine was administered. Twenty-five minutes after amphetamine administration, behavioral (crossing, rearing, time of stereotypy and immobility) and biochemical (MAO activity, DCFH-DA oxidation, protein and non-protein thiol groups) parameters were analyzed. Amphetamine increased the number of crossing and rearing and (PhSe)2 prevented only the increase in the number of crossings when acutely administered to mice. Furthermore, amphetamine increased stereotypy and time of immobility in mice. (PhSe)2, at 10 mg/kg, increased per se the stereotypy and time of immobility when sub-chronically administered. (PhSe)2, at 10 mg/kg, potentiated the stereotypy caused by amphetamine in both protocols. Sub-chronic treatment with (PhSe)2 either alone (5 and 10 mg/kg) or in combination (10 mg/kg) with amphetamine decreased brain MAO-B activity. Oxidative stress parameters were not modified by (PhSe)2 and/or amphetamine treatments. In conclusion, sub-chronic administration of (PhSe)2 can promote a behavioral sensitization that seems to be, at least in part, dependent of MAO-B inhibition.
Similar content being viewed by others
References
Acker CI, Luchese C, Prigol M, Nogueira CW (2009) Antidepressant-like effect of diphenyl diselenide on rats exposed to malathion: involvement of Na+K+-ATPase activity. Neurosci Lett 455:168–172. doi:10.1016/j.neulet.2009.03.069
Broadhurst PL (1960) Experiments in psychogenetics. In: Eysenk HJ (ed) Experiments in personality. Routledge & Kegan Paul, London, p 76
Brüning CA, Prigol M, Luchese C, Pinton S, Nogueira CW (2012) Diphenyl diselenide ameliorates behavioral and oxidative parameters in an animal model of mania induced by ouabain. Prog Neuropsychopharmacol Biol Psychiatry 38:168–174. doi:10.1016/j.pnpbp.2012.03.005
Burger M, Fachinetto R, Calegari L, Paixão MW, Braga AL, Rocha JB (2004) Effects of age on reserpine-induced orofacial dyskinesia and possible protection of diphenyl diselenide. Brain Res Bull 64:339–345. doi:10.1016/j.brainresbull.2004.09.006
Burger ME, Fachinetto R, Wagner C, Perottoni J, Pereira RP, Zeni G, Rocha JB (2006) Effects of diphenyl-diselenide on orofacial dyskinesia model in rats. Brain Res Bull 70:165–170. doi:10.1016/j.brainresbull.2006.05.002
Busanello A, Barbosa NB, Peroza LR, Farias LE, Burger ME, Barreto KP, Fachinetto R (2011) Resveratrol protects against a model of vacuous chewing movements induced by reserpine in mice. Behav Pharmacol 22:71–75. doi:10.1097/FBP.0b013e328341e9b4
Busanello A, Peroza LR, Wagner C, Sudati JH, Pereira RP, Prestes Ade S, Rocha JB, Fachinetto R, Barbosa NB (2012) Resveratrol reduces vacuous chewing movements induced by acute treatment with fluphenazine. Pharmacol Biochem Behav 101:307–310. doi:10.1016/j.pbb.2012.01.007
Chang LW (1983) Protective effects of selenium against methylmercury neurotoxicity: a morphological and biochemical study. Exp Pathol 23:143–156
Corte CL, Fachinetto R, Puntel R, Wagner C, Nogueira CW, Soares FA, Rocha JB (2009) Chronic treatment with fluphenazine alters parameters of oxidative stress in liver and kidney of rats. Basic Clin Pharmacol Toxicol 105:51–57. doi:10.1111/j.1742-7843.2009.00417.x
Ellman GL (1959) Tissue sulphydryl groups. Arch Biochem Biophys 82:70–77. doi:10.1016/0003-9861(59)90090-6
Engman L, Cotgreave I, Angulo M, Taylor CW, Paine-Murrieta GD, Powis G (1997) Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents. Anticancer Res 17:4599–4605
Fachinetto R, Villarino JG, Wagner C, Pereira RP, Puntel RL, Paixão MW, Braga AL, Calixto JB, Rocha JBT, Ferreira J (2007) Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats. Psychopharmacology 194:423–432. doi:10.1007/s00213-007-0831-y
Flohe L, Günzler WA, Schock HH (1973) Glutathione peroxidase: a selenoenzyme. FEBS Lett 32:132–134
Fornai F, Chen K, Giorgi FS, Gesi M, Alessandri MG, Shih JC (1999) Striatal dopamine metabolism in monoamine oxidase B-deficient mice: a brain dialysis study. J Neurochem 73:2434–2440. doi:10.1046/j.1471-4159.1999.0732434.x
Hoffman BJ, Hansson SR, Mezey E, Palkovits M (1998) Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system. Front Neuroendocrinol 19:187–231. doi:10.1006/frne.1998.0168
Kade IJ, Balogun BD, Rocha JB (2013) In vitro glutathione peroxidase mimicry of ebselen is linked to its oxidation of critical thiols on key cerebral sulphydryl proteins—a novel component of its GPx-mimic antioxidant mechanism emerging from its thiol-modulated toxicology and pharmacology. Chem Biol Interact 206:27–36. doi:10.1016/j.cbi.2013.07.014
Khan HA (2010) Selenium partially reverses the depletion of striatal dopamine and its metabolites in MPTP-treated C57BL mice. Neurochem Int 57:489–491. doi:10.1016/j.neuint.2010.06.020
Machado MS, Rosa RM, Dantas AS, Reolon GK, Appelt HR, Braga AL, Henriques JA, Roesler R (2006) An organic selenium compound attenuates apomorphine-induced stereotypy in mice. Neurosci Lett 410:198–202
Meltzer HY, Stahl SM (1976) The dopamine hypothesis of schizophrenia: a review. Schizophr Bull 2:19–76. doi:10.1093/schbul/2.1.19
Nogueira CW, Rocha JBT (2010) Diphenyl diselenide a janus-faced molecule. J Braz Chem Soc 21:2055–2071. doi:10.1590/S0103-50532010001100006
Nogueira CW, Rocha JBT (2011) Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds. Arch Toxicol 85:1313–1359. doi:10.1007/s00204-011-0720-3
Nogueira CW, Zeni G, Rocha JB (2004) Organoselenium and organotellurium compounds: toxicology and pharmacology. Chem Rev 104:6255–6285. doi:10.1021/cr0406559
Pereira RP, Fachinetto R, de Souza Prestes A, Wagner C, Sudati JH, Boligon AA, Athayde ML, Morsch VM, Rocha JB (2011) Valeriana officinalis ameliorates vacuous chewing movements induced by reserpine in rats. J Neural Transm 118:1547–1557. doi:10.1007/s00702-011-0640-7
Pérez-Severiano P, Rodríguez-Pérez M, Pedraza-Chaverrí J, Maldonado PD, Medina-Campos ON, Ortíz-Plata A, Sánchez-García A, Villeda-Hernández J, Galván-Arzate S, Aguilera P, Santamaría A (2004) S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats. Neurochem Int 45:1175–1183. doi:10.1016/j.neuint.2004.06.008
Pontieri FE, Tanda G, Chiara G (1995) Intravenous cocaine, morphine, and amphetamine preferential increase extracellular dopamine in the “shell” as compared with the “core” of the rat nucleus accumbens. Proc Natl Acad Sci USA 92:12304–12308
Rasekh HR, Davis MD, Cooke LW, Mazzio EA, Reams RR, Soliman KF (1997) The effect of selenium on the central dopaminergic system: a microdialysis study. Life Sci 61:1029–1035
Rayman MP, Infante HG, Sargent M (2008) Food-chain selenium and human health: spotlight on speciation. Br J Nutr 100:238–253. doi:10.1017/S0007114508922522
Redgrave P, Rodriguez M, Smith Y, Rodriguez-Oroz MC, Lehericy S, Bergman H, Agid Y, DeLong MR, Obeso JA (2010) Goal-directed and habitual control in the basal ganglia: implications for Parkinson’s disease. Nat Rev Neurosci 11:760–772. doi:10.1038/nrn2915
Rocha JT, Gai BM, Pinton S, Sampaio TB, Nogueira CW, Zeni G (2012a) Effects of diphenyl diselenide on depressive-like behavior in ovariectomized mice submitted to subchronic stress: involvement of the serotonergic system. Psychopharmacology 222:709–719. doi:10.1007/s00213-012-2675-3
Rocha JBT, Saraiva RA, Garcia SC, Gravina FS, Nogueira CW (2012b) Aminolevulinate dehydratase (δ-ALA-D) as marker protein of intoxication with metals and other pro-oxidant situations. Toxicol Res 1:85–102. doi:10.1039/C2TX20014G
Savegnago L, Jesse CR, Pinto LG, Rocha JBT, Nogueira CW, Zeni G (2007) Monoaminergic agents modulate antidepressant-like effect caused by diphenyl diselenide in rats. Prog Neuro Psychopharmacol Biol Psychiatry 31:1261–1269. doi:10.1016/j.pnpbp.2007.05.006
Savegnago L, Jesse CR, Pinto LG, Rocha JBT, Barancelli DA, Nogueira CW, Zeni G (2008) Diphenyl diselenide exerts antidepressant-like and anxiolytic-like effects in mice: involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway in its antidepressant-like action. Pharmacol Biochem Behav 88:418–426. doi:10.1016/j.pbb.2007.09.015
Tang YL, Wang SW, Lin SM (2008) Both inorganic and organic selenium supplements can decrease brain monoamine oxidase B enzyme activity in adult rats. Br J Nutr 100:660–665. doi:10.1017/S0007114508911594
Villarinho JG, Fachinetto R, Pinheiro F, Sant’Anna GS, Machado P, Dombrowski PA, Da Cunha C, Cabrini DA, Martins MAP, Bonacorso HG, Zanatta N, Rubin MA, Ferreira J (2012) Antidepressant-like effect of the novel MAO inhibitor 2-(3,4-dimethoxy-phenyl)-4,5-dihydro-1H-imidazole (2-DMPI) in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 39:31–39. doi:10.1016/j.pnpbp.2012.04.007
Wolgin DL (2012) Amphetamine stereotypy, the basal ganglia, and the “selection problem”. Behav Brain Res 231:297–308. doi:10.1016/j.bbr.2011.11.003
Youdim MBH, Bakhle YS (2006) Monoamine oxidase: isoforms and inhibitors in Parkinson´s disease and depressive illness. Br J Pharmacol 147:287–296. doi:10.1038/sj.bjp.0706464
Youdim MBH, Edmondson D, Tripton KF (2006) The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 7:295–309. doi:10.1038/nrn1883
Zafar KS, Siddiqui A, Sayeed I, Ahmad M, Salim S, Islam F (2003) Dose-dependent protective effect of selenium in rat model of Parkinson’s disease: neurobehavioral and neurochemical evidences. J Neurochem 84:438–446. doi:10.1046/j.1471-4159.2003.01531.x
Acknowledgments
This work was supported by the PRONEM#11/2029-1, PRONEX/FAPERGS and INCT-CNPq for Excitotoxicity and Neuroprotection. J.B.T. received a fellowship from CNPq. J.R.R. and E.M.R. received a fellowship from CAPES. C.Q.L. received a fellowship from PIBIC/CNPq.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Figueira, F.H., Leal, C.Q., de Moraes Reis, E. et al. Effects of diphenyl diselenide on behavioral and biochemical changes induced by amphetamine in mice. J Neural Transm 122, 201–209 (2015). https://doi.org/10.1007/s00702-014-1257-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-014-1257-4